美国梅奥诊所（Mayo clinic）为美国最佳医院综合排名第一（2016-17年）
期刊影响因子20以上，H指数130以上的论文917篇分布如下：
数据来源 http://www.pubmedplus.cn/
01.rochester.mn 180 篇19.629% 03.rochester.ny 59 篇6.434% 04.jacksonville 44 篇4.798% 16.victoria.au 20 篇2.181% 19.rochester.uk 19 篇2.072% 28.mount sinai 16 篇1.745% 34.帕拉托市(斯坦福大学) 14 篇1.527% 36.美国北卡罗来纳州教堂山镇 14 篇1.527% 38.kettering.us 13 篇1.418% 40.美国华盛顿哥伦比亚特区 13 篇1.418% 43.italy.centro 12 篇1.309% 45.victoria.canada 12 篇1.309% 01.Loprinzi CL 31 篇3.381% 05.Mailliard JA 18 篇1.963% 09.Goldberg RM 15 篇1.636% 查看更多
03.mayo clinic and foundation 45 篇4.907% 07.纪念斯隆-凯特琳癌症中心 24 篇2.617% 18.美国丹那法伯肿瘤研究所 17 篇1.854% 21.美国德州大学md安德森癌症中心 15 篇1.636% 28.加州大学旧金山分校医学中心 12 篇1.309% 31.美国加州大学洛杉矶分校 12 篇1.309% 38.mayo clinic arizona 10 篇1.091% 45.加州大学洛杉矶分校医学中心 9 篇0.981% 01.treatment outcome 68 篇7.415% 02.antineoplastic combined chemotherapy protocols 61 篇6.652% 03.breast neoplasms 57 篇6.216% 05.risk factors 55 篇5.998% 06.follow-up studies 54 篇5.889% 07.double-blind method 53 篇5.780% 08.survival analysis 52 篇5.671% 10.prospective studies 43 篇4.689% 11.antineoplastic agents 32 篇3.490% 12.disease-free survival 32 篇3.490% 13.retrospective studies 32 篇3.490% 14.genetic predisposition to disease 31 篇3.381% 15.randomized controlled trials as topic 30 篇3.272% 16.combined modality therapy 29 篇3.162% 17.molecular sequence data 28 篇3.053% 18.quality of life 28 篇3.053% 19.time factors 27 篇2.944% 20.fluorouracil 26 篇2.835% 22.neoplasm recurrence, local 26 篇2.835% 24.survival rate 26 篇2.835% 25.cohort studies 25 篇2.726% 27.drug administration schedule 24 篇2.617% 28.kaplan-meier estimate 24 篇2.617% 29.polymorphism, single nucleotide 24 篇2.617% 30.proportional hazards models 24 篇2.617% 31.colorectal neoplasms 23 篇2.508% 32.practice guidelines as topic 23 篇2.508% 33.signal transduction 23 篇2.508% 34.disease progression 22 篇2.399% 35.neoplasm staging 22 篇2.399% 36.diagnosis, differential 21 篇2.290% 37.genome-wide association study 21 篇2.290% 38.multivariate analysis 20 篇2.181% 39.prostatic neoplasms 20 篇2.181% 40.cyclophosphamide 19 篇2.072% 41.lung neoplasms 19 篇2.072% 42.neoplasm metastasis 19 篇2.072% 43.adenocarcinoma 18 篇1.963% 47.heart failure 17 篇1.854% 48.myocardial infarction 17 篇1.854% 49.base sequence 16 篇1.745% 50.chemotherapy, adjuvant 16 篇1.745% 01.antineoplastic agents 32 篇3.490% 02.fluorouracil 26 篇2.835% 03.cyclophosphamide 19 篇2.072% 04.dna-binding proteins 15 篇1.636% 05.antibodies, monoclonal, humanized 14 篇1.527% 06.doxorubicin 14 篇1.527% 07.anticoagulants 13 篇1.418% 08.antibodies, monoclonal 12 篇1.309% 10.membrane proteins 12 篇1.309% 查看更多
04.皮肤与结缔组织疾病 103 篇11.232% 18.女性泌尿生殖器疾病和妊娠并发症 58 篇6.325% 33.先天性遗传性新生儿疾病和畸形 40 篇4.362%
https://blog.sciencenet.cn/blog-280034-994092.html
上一篇：
韩春雨论文争议最新进展（7月31日-8月2日）下一篇：
美国梅奥诊所与中国大陆重大科研合作项目
